{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T06:40:09Z","timestamp":1739515209177,"version":"3.37.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,13]]},"DOI":"10.7759\/cureus.78970","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T06:00:26Z","timestamp":1739512826000},"source":"Crossref","is-referenced-by-count":0,"title":["Laparoscopic Resection of Central Ovarian Cancer Recurrence in the Pelvis Utilizing a Fluorescent Ureteral Near-Infrared Ray Catheter (NIRC): A Case Report"],"prefix":"10.7759","author":[{"given":"Takashi","family":"Natsume","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Kobayashi-Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Tanase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuya","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel RL","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020, 70:7-30. 10.3322\/caac.21590","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902626","article-title":"Secondary surgical cytoreduction for recurrent ovarian cancer","volume":"381","author":"Coleman RL","year":"2019","unstructured":"Coleman RL, Spirtos NM, Enserro D, et al.. Secondary surgical cytoreduction for recurrent ovarian cancer. N Engl J Med. 2019, 381:1929-39. 10.1056\/NEJMoa1902626","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMx220002","article-title":"Randomized trial of cytoreductive surgery for relapsed ovarian cancer","volume":"385","author":"Harter P","year":"2021","unstructured":"Harter P, Sehouli J, Vergote I, et al.. Randomized trial of cytoreductive surgery for relapsed ovarian cancer. N Engl J Med. 2021, 385:2123-31. 10.1056\/NEJMx220002","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2014.11.008","article-title":"Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes","volume":"22","author":"Fagotti A","year":"2015","unstructured":"Fagotti A, Costantini B, Gallotta V, et al.. Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes. J Minim Invasive Gynecol. 2015, 22:428-32. 10.1016\/j.jmig.2014.11.008","journal-title":"J Minim Invasive Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.01.015","article-title":"Analysis of secondary cytoreduction for recurrent ovarian cancer by robotics, laparoscopy and laparotomy","volume":"129","author":"Magrina JF","year":"2013","unstructured":"Magrina JF, Cetta RL, Chang YH, Guevara G, Magtibay PM. Analysis of secondary cytoreduction for recurrent ovarian cancer by robotics, laparoscopy and laparotomy. Gynecol Oncol. 2013, 129:336-40. 10.1016\/j.ygyno.2013.01.015","journal-title":"Gynecol Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2014.01.006","article-title":"Urinary tract injuries in laparoscopic hysterectomy: a systematic review","volume":"21","author":"Adelman MR","year":"2014","unstructured":"Adelman MR, Bardsley TR, Sharp HT. Urinary tract injuries in laparoscopic hysterectomy: a systematic review. J Minim Invasive Gynecol. 2014, 21:558-66. 10.1016\/j.jmig.2014.01.006","journal-title":"J Minim Invasive Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58121869","article-title":"Urologic complication after laparoscopic hysterectomy in gynecology oncology: a single-center analysis and narrative review of the literature","volume":"58","author":"Capozzi VA","year":"2022","unstructured":"Capozzi VA, Monfardini L, Scarpelli E, et al.. Urologic complication after laparoscopic hysterectomy in gynecology oncology: a single-center analysis and narrative review of the literature. Medicina (Kaunas). 2022, 58:1869. 10.3390\/medicina58121869","journal-title":"Medicina (Kaunas)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-021-06103-w","article-title":"A novel near-infrared ray catheter fluorescent ureteral catheter for preventing ureteral injury in gynecologic laparoscopic surgery","volume":"304","author":"Kisu I","year":"2021","unstructured":"Kisu I, Shiraishi T, Iijima M, Nakamura K, Matsuda K, Hirao N. A novel near-infrared ray catheter fluorescent ureteral catheter for preventing ureteral injury in gynecologic laparoscopic surgery. Arch Gynecol Obstet. 2021, 304:283-4. 10.1007\/s00404-021-06103-w","journal-title":"Arch Gynecol Obstet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.52054\/FVVO.15.1.060","article-title":"Laparoscopic selection for surgery in epithelial ovarian cancer. A short review","volume":"15","author":"Ghirardi V","year":"2023","unstructured":"Ghirardi V, Fagotti A, Scambia G. Laparoscopic selection for surgery in epithelial ovarian cancer. A short review. Facts Views Vis Obgyn. 2023, 15:25-8. 10.52054\/FVVO.15.1.060","journal-title":"Facts Views Vis Obgyn"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore K","year":"2018","unstructured":"Moore K, Colombo N, Scambia G, et al.. Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. N Engl J Med. 2018, 379:2495-505. 10.1056\/NEJMoa1810858","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00073-5","article-title":"Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1\/2 mutation (SOLO2\/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"22","author":"Poveda A","year":"2021","unstructured":"Poveda A, Floquet A, Ledermann JA, et al.. Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1\/2 mutation (SOLO2\/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Oncol. 2021, 22:620-31. 10.1016\/S1470-2045(21)00073-5","journal-title":"Lancet Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.09.3110","article-title":"Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO\/ENGOT-ov38): a phase IIIb trial","volume":"34","author":"Pujade-Lauraine E","year":"2023","unstructured":"Pujade-Lauraine E, Selle F, Scambia G, et al.. Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO\/ENGOT-ov38): a phase IIIb trial. Ann Oncol. 2023, 34:1152-64. 10.1016\/j.annonc.2023.09.3110","journal-title":"Ann Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1196496","article-title":"The role of minimally invasive surgery in epithelial ovarian cancer treatment: a narrative review","volume":"10","author":"Generali M","year":"2023","unstructured":"Generali M, Annunziata G, Pirillo D, D'Ippolito G, Ciarlini G, Aguzzoli L, Mandato VD. The role of minimally invasive surgery in epithelial ovarian cancer treatment: a narrative review. Front Med (Lausanne). 2023, 10:1196496. 10.3389\/fmed.2023.1196496","journal-title":"Front Med (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/338395-laparoscopic-resection-of-central-ovarian-cancer-recurrence-in-the-pelvis-utilizing-a-fluorescent-ureteral-near-infrared-ray-catheter-nirc-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T06:00:27Z","timestamp":1739512827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/338395-laparoscopic-resection-of-central-ovarian-cancer-recurrence-in-the-pelvis-utilizing-a-fluorescent-ureteral-near-infrared-ray-catheter-nirc-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.78970","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,13]]}}}